 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||| SNP-ACTH (1-39) Gel / Cerium Pharma
Enrollment open, Head-to-Head: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy (clinicaltrials.gov) - Jun 5, 2023
P3, N=148, Recruiting, Sponsor: Cerium Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting
- | SNP-ACTH (1-39) Gel / Cerium Pharma
New P3 trial, Head-to-Head: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy (clinicaltrials.gov) - Jan 25, 2023
P3, N=148, Not yet recruiting, Sponsor: Cerium Pharmaceuticals, Inc.